Apollomics Announces $2.0M Convertible Bridge Financing

Apollomics Inc. (Nasdaq: APLM) announced it entered into a $2.0 million unsecured convertible promissory note with its Chairman and CEO, Mr. Hung-Wen (Howard) Chen, dated March 30, 2026. The note provides proceeds intended for working capital to support clinical development programs and general corporate operations.

The note carries 0% interest and automatically converts into equity securities upon the closing of a subsequent equity financing with aggregate gross proceeds of at least $10.0 million. The conversion price is set at a 20% discount to the lowest per-share price issued in that financing.

The related-party terms were reviewed and approved by the company’s independent audit committee and board, with Mr. Chen abstaining.